“SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024020. doi:10.4084/MJHID.2024.020.